ClinicalTrials.Veeva

Menu

Investigation of the Epidemiological Factors Associated With the Development of Amyotrophic Lateral Sclerosis (ALS) (EpidALS)

H

Hadassah Medical Center

Status

Enrolling

Conditions

ALS

Treatments

Other: Observation

Study type

Observational

Funder types

Other

Identifiers

NCT03366506
0633-08-HMO-CTIL

Details and patient eligibility

About

Investigation of the epidemiological factors associated with amyotrophic lateral sclerosis (ALS) in Israel with a view to future international collaboration. Particularly addressing:-

  1. Differences between ethnic subgroups
  2. Differences between immigrant and native-born populations
  3. Differences according to military service profile Clinical features gathered at each routine visit ,throughout the entire course of the disease, will be recorded in database format, in order to correlate with potential epidemiological factors.

Full description

Investigation of the epidemiological factors associated with amyotrophic lateral sclerosis (ALS) in Israel with a view to future international collaboration. Particularly addressing:-

  1. Differences between ethnic subgroups
  2. Differences between immigrant and native-born populations
  3. Differences according to military service profile Clinical features gathered at each routine visit ,throughout the entire course of the disease, will be recorded in database format, in order to correlate with potential epidemiological factors.

The clinical features will include pattern of onset, details of full clinical exam ( including ALSFRS-R score, power, reflexes, and other signs of upper or lower-motor neuron dysfunction.

Correlations between different clinical parameters themselves will be made, as well as correlation between clinical parameters and other epidemiological factors.

Enrollment

2,000 estimated patients

Sex

All

Ages

12 to 120 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Suspected, possible, probable ,definite ALS

Exclusion criteria

Trial design

2,000 participants in 1 patient group

ALS patients
Description:
ALS patients ( suspected, possible, probable or definite per El-Escorial criteria). Observation
Treatment:
Other: Observation

Trial contacts and locations

1

Loading...

Central trial contact

Marc Gotkine, MBBS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems